ArticleOncology letters2025
Pancreatic liposarcoma: A case report.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary liposarcoma (LPS) of the pancreas is extremely rare. The present report describes an additional case of primary pancreatic LPS and reviews the current literature. A 40-year-old female patient that initially presented with a fever was subsequently found to have a pancreatic tumor. CT was used to identify a heterogeneous mass in the pancreatic head and body, which had a notable absence of fat components. The tumor exhibited slightly heterogeneous enhancement during the arterial phase, moderate enhancement in the venous phase and persistent enhancement in the delayed phase, with encapsulation of the common hepatic artery, splenic vein and portal vein. The patient underwent a successful distal pancreatectomy and splenectomy. Pathological examination and next-generation sequencing confirmed the diagnosis of dedifferentiated LPS (DDLPS). The present report elucidated the CT findings of this rare case of DDLPS of the pancreas, characterized by vascular invasion and progressive enhancement but without fat components, which can serve as a reference for the diagnosis of this uncommon tumor. The uncommon CT manifestation makes differentiation from pancreatic neuroendocrine tumors particularly challenging based on imaging characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.